Done with errors on the page
Done with errors on the page
This role may be eligible for the Queensland Health Attraction Incentive. See link - Workforce Attraction Incentive Guideline Scheme ( https://www.careers.health.qld.gov.au/working-for-us/workforce-attraction-incentive-scheme )
The Cancer Inpatient Unit (CIPU) is an eleven-bed unit, located on level 5 New Wing Block, Rockhampton Hospital. The unit is part of Cancer Care Services model of care. Cancer Care consists of care provision by Medical Oncology, Haematology, Radiation Oncology, and Specialist Palliative Care. provides specialist care for patients.
The Clinical Facilitator (CF) provides an early leadership role within the career pathway for nursing within Central Queensland (CQ) Health. The CF actively engages in the development of a learning culture within the clinical unit and models evidence-based practice at an advanced level relevant to Cancer and Palliative Care nursing.
The CF follows defined service quality standards, occupational health and safety policies and procedures relating to the work being undertaken to ensure high quality, safe, practice and services and workplaces.
The CF provides leadership and contribute to the development of clinical practice by:
Salary information:
Total remuneration value of up to $65,949 p.a. is comprised of:
Other benefits include:
It is a condition of employment for this role for the employee to be, and remain, vaccinated against vaccine preventable diseases as listed on the Role Description.
To submit your application / expression of interest, please include:
Please note pre-employment checks will be carried out on applicants recommended for appointment/employment which may include confirming your qualifications, professional registration/s, previous employment history (including any previous disciplinary action), criminal history, Australian work status and vaccination requirements.
For assistance, contact Recruitment Services @ CQ Health ( mailto:[email protected] ) and quote the Job Ad Reference (JAR) RK4D558324
Applications close: Monday, 29 April 2024